Tet methylcytosine dioxygenase 2 (TET2) deficiency elicits EGFR-TKI (tyrosine kinase inhibitors) resistance in non-small cell lung cancer.
Zhang J, Zhao K, Zhou W, Kang R, Wei S, Shu Y, Yu C, Ku Y, Mao Y, Luo H, Yang J, Mei J, Pu Q, Deng S, Zha Z, Yuan G, Shen S, Chen Y, Liu L.
Zhang J, et al. Among authors: pu q.
Signal Transduct Target Ther. 2024 Mar 9;9(1):65. doi: 10.1038/s41392-024-01778-4.
Signal Transduct Target Ther. 2024.
PMID: 38461173
Free PMC article.